P&G Health's Q2 net profit declined 6% to Rs 72 crore, impacted by a slowdown in the vitamins, minerals and supplements category. The company declared an interim dividend of Rs 200 per share.
New Delhi, Feb 6 (PTI) Procter & Gamble Health Ltd on Tuesday said its profit after tax declined 6 per cent to Rs 72 crore for the second quarter ended December 2023.
The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal.
Total income for the period under review stood at Rs 315 crore as against Rs 314 crore in the year-ago period, Procter & Gamble Health said in a regulatory filing.
The company follows a July-June financial year.
"This has been a challenging quarter for the company on account of an overall slowdown in the vitamins, minerals and supplements category coupled with a delayed seasonal onset," P&G Health India MD Milind Thatte said.
With improved productivity, efficiency and continued strategic investments, the company has been able to deliver a modest topline and bottomline, he added.
The company said its board has declared an interim dividend of Rs 200 per share for the financial year 2023-24.
Shares of the company settled 3.7 per cent higher at Rs 5,328.50 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback